Financial Deals Industry Tracker: Pharmaceuticals and Healthcare May 2008

Synopsis

Analysis and opinion on monthly deal activity, along with the trend for the last six months for merger and acquisition (M&A), private equity, private placement, IPO, and secondary offering deals.

Introduction

This report contains extensive qualitative and quantitative analysis of monthly deal activity (including strategic alliances) in the biotechnology, healthcare services, medical devices, and pharmaceuticals sectors across global markets, with a specific focus on key emerging markets. It offers insights into deal activity, deal rationale, and valuation trends.

Scope

• Insights into deal activity across M&A, private equity, private placement, IPO, and secondary offering deals 
• In-depth analysis on all key sectors, namely biotechnology, healthcare services, medical devices, and pharmaceuticals
• Geographical trends by primary regions and by key emerging markets
• Detailed analysis of the deal activity during the month, along with the trend for the last six months by deal volume and value

Highlights

M&A transactions recorded a decline of 31.4% in value terms, although the pharmaceutical sector witnessed a few big ticket acquisitions. The biotechnology segment dominated M&A activity in May, driven by the significant interest in the oncology and vaccine markets, which is likely to continue.The home healthcare segment is likely to experience more M&A activity, as companies look to expand their presence; private equity players remain interested in other services. On-going consolidation in the generic drug markets and emerging economies dominated the deal activity in the pharmaceutical segment.Venture capitalists invested over $651 million in 52 companies, a decrease of 37.4% in value terms as compared to the last six month average. The pharmaceutical and healthcare sector recorded 11 public offerings, an increase of 22.2% on a month-on-month basis, indicating improved capital market conditions.

Reason to Purchase

• Understand which sectors are experiencing the most activity, and which type of investor, and advisor are playing the significant roles
• Find out how key deals are changing the competitive landscape of your business 
• Find out how companies in pharmaceuticals and healthcare industry are raising funds through capital markets, private equity, and private placement deals

TABLE OF CONTENTS

1. Introduction
a. About Financial Deals
b. About this report

2. Mergers and acquisitions (including private equity deals)
a. Monthly roundup
i. Biotechnology
ii. Healthcare services
iii. Pharmaceuticals
iv. Medical devices
b. Volume and value analysis by sector
c. Volume analysis by geography
i. Global regions (North America, Europe, Asia Pacific, and Rest of World)
ii. Emerging markets (BRIC, Middle East, Eastern Europe, Latin America, and Africa)
d. Value analysis by geography
i. Global regions (North America, Europe, Asia Pacific, and Rest of World)
ii. Emerging markets (BRIC, Middle East, Eastern Europe, Latin America, and Africa)
e. Trend analysis by deal size
f. Advisory ranking M&A (trailing six months) – financial and legal
g. Private equity firm ranking

3. Venture financing
a. Monthly roundup
b. Volume and value analysis by sector
c. Volume and value analysis by geography
d. Trend analysis by deal size
e. Venture finance firm ranking

4. Public offering
a. Monthly roundup
b. Volume and value analysis by sector
c. Volume and value analysis by geography
d. Trend analysis by deal size

5. Private placement
a. Monthly roundup
b. Volume and value analysis by sector
c. Volume and value analysis by geography
d. Trend analysis by deal size

6. Advisory ranking for all deals (trailing six months) – financial and legal

7. Appendix
a. Definition
b. Disclaimer